Attention deficit hyperactivity disorder (ADHD) occurs in approximately 4.4% of adults, with the incidence in females approaching that of males. Thus, ADHD is now being diagnosed in millions of women worldwide. Despite this, few women receive the comprehensive evaluation needed to delineate the full array of symptoms as they appear in females, including cognitive, anxiety and mood disorders. Even fewer receive a comprehensive treatment programme to address these symptoms and optimise daily functioning.